Scpharmaceuticals Stock Technical Analysis
| SCPH Stock | USD 4.42 0.25 5.35% |
As of the 18th of April 2024, Scpharmaceuticals has the Variance of 14.69, risk adjusted performance of (0.05), and Coefficient Of Variation of (1,001). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Scpharmaceuticals, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to interpolate data for thirteen technical drivers for Scpharmaceuticals, which can be compared to its competition. Please validate Scpharmaceuticals market risk adjusted performance, variance, as well as the relationship between the Variance and value at risk to decide if Scpharmaceuticals is priced more or less accurately, providing market reflects its prevalent price of 4.42 per share. Given that Scpharmaceuticals has information ratio of (0.11), we advise you to double-check Scpharmaceuticals's current market performance to make sure the company can sustain itself at a future point.
Scpharmaceuticals Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Scpharmaceuticals, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ScpharmaceuticalsScpharmaceuticals |
Scpharmaceuticals Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 19.33 | Strong Buy | 6 | Odds |
Most Scpharmaceuticals analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Scpharmaceuticals stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Scpharmaceuticals, talking to its executives and customers, or listening to Scpharmaceuticals conference calls.
Scpharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Scpharmaceuticals Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Scpharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Scpharmaceuticals Trend Analysis
Use this graph to draw trend lines for Scpharmaceuticals. You can use it to identify possible trend reversals for Scpharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Scpharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Scpharmaceuticals Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Scpharmaceuticals applied against its price change over selected period. The best fit line has a slop of 0.01 , which may suggest that Scpharmaceuticals market price will keep on failing further. It has 122 observation points and a regression sum of squares at 4.03, which is the sum of squared deviations for the predicted Scpharmaceuticals price change compared to its average price change.About Scpharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Scpharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Scpharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Scpharmaceuticals price pattern first instead of the macroeconomic environment surrounding Scpharmaceuticals. By analyzing Scpharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Scpharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Scpharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2010 | 2023 | 2024 (projected) | Dividend Yield | 3.71E-4 | 3.05E-4 | 3.51E-4 | Price To Sales Ratio | 17.77 | 15.99 | 14.22 |
Scpharmaceuticals April 18, 2024 Technical Indicators
Most technical analysis of Scpharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Scpharmaceuticals from various momentum indicators to cycle indicators. When you analyze Scpharmaceuticals charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (0.18) | |||
| Mean Deviation | 3.09 | |||
| Coefficient Of Variation | (1,001) | |||
| Standard Deviation | 3.83 | |||
| Variance | 14.69 | |||
| Information Ratio | (0.11) | |||
| Jensen Alpha | (0.48) | |||
| Total Risk Alpha | (0.67) | |||
| Treynor Ratio | (0.19) | |||
| Maximum Drawdown | 16.0 | |||
| Value At Risk | (5.83) | |||
| Potential Upside | 6.51 | |||
| Skewness | 0.5939 | |||
| Kurtosis | (0.02) |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Scpharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in Scpharmaceuticals Stock please use our How to Invest in Scpharmaceuticals guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for Scpharmaceuticals Stock analysis
When running Scpharmaceuticals' price analysis, check to measure Scpharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scpharmaceuticals is operating at the current time. Most of Scpharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Scpharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scpharmaceuticals' price. Additionally, you may evaluate how the addition of Scpharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |
Is Scpharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Scpharmaceuticals. If investors know Scpharmaceuticals will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Scpharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.42) | Revenue Per Share 0.353 | Return On Assets (0.32) | Return On Equity (1.00) |
The market value of Scpharmaceuticals is measured differently than its book value, which is the value of Scpharmaceuticals that is recorded on the company's balance sheet. Investors also form their own opinion of Scpharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Scpharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Scpharmaceuticals' market value can be influenced by many factors that don't directly affect Scpharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Scpharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Scpharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Scpharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.